A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery

9K views

⸱

DOI:

10.3791/54018

⸱

August 23rd, 2016

 ,  ,  ,  ,  ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

Epithelial to mesenchymal transition (EMT) allows cancers to become invasive. To investigate EMT, a neural stem cell (NSC)-based in vitro model devoid of serum and enzymes is described. This standardized system allows quantitative and qualitative assessment of cell migration, gene and protein expression. The model is suited for drug discovery.

Abstract

Epithelial to mesenchymal transition (EMT) describes the process of epithelium transdifferentiating into mesenchyme. EMT is a fundamental process during embryonic development that also commonly occurs in glioblastoma, the most frequent malignant brain tumor. EMT has also been observed in multiple carcinomas outside the brain including breast cancer, lung cancer, colon cancer, gastric cancer. EMT is centrally linked to malignancy by promoting migration, invasion and metastasis formation. The mechanisms of EMT induction are not fully understood. Here we describe an in vitro system for standardized isolation of cortical neural stem cells (NSCs) and subsequent EMT-induction. This system provides the flexibility to use either single cells or explant culture. In this system, rat or mouse embryonic forebrain NSCs are cultured in a defined medium, devoid of serum and enzymes. The NSCs expressed Olig2 and Sox10, two transcription factors observed in oligodendrocyte precursor cells (OPCs). Using this system, interactions between FGF-, BMP- and TGFβ-signaling involving Zeb1, Zeb2, and Twist2 were observed where TGFβ-activation significantly enhanced cell migration, suggesting a synergistic BMP-/TGFβ-interaction. The results point to a network of FGF-, BMP- and TGFβ-signaling to be involved in EMT induction and maintenance. This model system is relevant to investigate EMT in vitro. It is cost-efficient and shows high reproducibility. It also allows for the comparison of different compounds with respect to their migration responses (quantitative distance measurement), and high-throughput screening of compounds to inhibit or enhance EMT (qualitative measurement). The model is therefore well suited to test drug libraries for substances affecting EMT.

Introduction

During several stages of embryonic development, epithelial cells lose their strong adherence to each other (e.g., tight junctions) and acquire a migratory phenotype in a process called epithelial to mesenchymal transition (EMT)1. EMT is required for the formation of additional cell types, such as the mesenchymal neural crest cells, a population that segregates from the neuroepithelium2. EMT is not only essential during embryonic stages but also required at later stages of adult life to maintain physiological processes in the adult organism, such as wound healing3and central nervous system (CNS) regeneration in demyelinating le....

Access restricted. Please log in or start a trial to view this content.

Protocol

All animal procedures followed the 'Guide for the Care and Use of Laboratory Animals' (NIH publication, 8th edition, 2011) and were approved by the Animal Welfare Committee of Basel (Swiss Guidelines for the Care and Use of Animals). By these guidelines the animal protocol is considered of "lowest animal severity grade".

1. Preparation of Expansion Medium

Note: Work in aseptic conditions as standard for tissue culture.

  1. Take two 15 ml tubes, and add 5 ml of L-glutamine-free DMEM/F12 (1:1) from a 500 ml medium bottle into each of the two 15 ml tubes. To the first 15 ml tube, add 50 mg human apo-transferrin, 50 μl....

Access restricted. Please log in or start a trial to view this content.

Results

This EMT model system is based on the standardized isolation of NSCs both as single cells or as explants from a specific region of the developing neural tube, the central cortex (Figures 1 and 2). For quantitative assessment, explants were seeded right at the center of a 500 µm grid culture dish (Figure 3). Explants from the central cortex were first exposed to FGF2 for two days, followed by additional two days in different combinations o.......

Access restricted. Please log in or start a trial to view this content.

Discussion

In this study a standardized system for EMT analysis utilizing NSCs is described (summarized in Supplementary Figure 3). The standardization ensures reproducibility (Table 1 and 2). The NSCs are derived from the developing cortex, a tissue that normally does not undergo EMT. This is of advantage for the analysis of early steps in EMT. Initial steps in EMT cannot be adequately studied in tumor cells that have accumulated genetic changes and may have already adopted EMT features. Moreover,.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

The study was supported by the University of Basel Science Foundation and the Swiss National Science Foundation by a grant to MHS and AG (SNF IZLIZ3_157230). We thank: Dr. Tania Rinaldi Burkat for generously providing infrastructure; all members of the Bettler group for discussions and comments. We thank Gerhard Dorne (Leica Microsystems, Switzerland) for professional and competent installation of the Full HD MC170 video camera (Leica Microsystems, Switzerland).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
BMP4, rhBMP4RnD Systems 314-BP-01M
Bovine pancreas insulinSigma I1882
Boyden chamber, CytoSelect cell invasion assayCell BiolabsCBA-11024 well plate system
Cell culture dish with gridIbidi 500 mm dish, 35 mm80156
CellMask OrangeLife TechnologiesC10045Plasma membrane dye, use at 1:1,000.
DAPILifeTechnologiesD1306Stock at 5 mg/ml. Use at 1:10,000. Cancerogenic. Appropriate protection (gloves, coat, goggles) required.
DMEM/F12 1:1 medium bottleGibco Invitrogen21331-020
FGF2, rhFGF2RnD Systems233-FB-01M
Fibronectine, bovineSigma F4759
Glutamax supplement Gibco Invitrogen 35050-061
Graphics software with pixel measurement featureFijifiji.sc/Fijiversion 2.0.0-rc-30/1.49s
HBSS mediaSigma H9394
Human apo-TransferrinSigmaT1147Possible lung irritant. Avoid inhalation. Use appropriate protection.
L-glutamineGibco Invitrogen 25030-024
Nestin, Mouse anti Nestin antibodyGenetexGTX26142Use at 1:100, 4% PFA fixation, Triton X100 at 0.1%
Olig2, Rabbit anti Olig2 antibodyProvided by Hirohide TakebayashPersonal stockUse at 1:2,000, 4% PFA fixation, Triton X100 at 0.1%
Penicillin/Streptomycin/FungizoneGibco Invitrogen 15240-062
Podoplanin, Mouse anti Podoplanin antibodyAcrisDM3614PUse at 1:250, 4% PFA fixation, avoid Triton X100
Poly-L-ornithineSigma P3655
PutrescineSigma P5780Skin and eye irritant. Appropriate protection required.
Sodium seleniteSigma S5261
Sox10, Rabbit anti Sox10 antibodyMillipore ChemiconAB5774Use at 1:200, 4% PFA fixation, Triton X100 at 0.1%
TGFb1, rhTGFb1RnD Systems240-B-010
Uncoated Petri dishesFalcon Corning351029

References

  1. Nieto, M. A. Epithelial-Mesenchymal Transitions in development and disease: old views and new perspectives. Int J Dev Biol. 53, 1541-1547 (2009).
  2. Sauka-Spengler, T., Bronner-Fraser, M. A gene regulatory network orchestrates neural crest formation.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Neural Stem CellsEMT InductionExplant CultureCell MigrationTGF Beta SignalingBMP4 TreatmentCortical DissectionFibronectin CoatingHigh Throughput Screening